Studies using mouse models of AD, rat neurons in vitro cultures, and samples from human Alzheimer’s patients have identified deficits in the Wnt/β-catenin signaling pathway that accounts for both the Aβ and tau pathogenesis seen in AD, as well as the characteristic bone loss of osteoporosis. This evidence concerns the gene MAPT and Alzheimer disease.